ng-nitroarginine methyl ester has been researched along with Chlamydia Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barteneva, NS; de la Maza, LM; Khatsenko, OG; Kikkawa, Y | 1 |
| Forslid, A; Johansson, L; Karnani, P; Laurini, R; Liuba, P; Paakkari, I; Persson, K; Pesonen, E; Wadström, T | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Chlamydia Infections
| Article | Year |
|---|---|
Role of nitric oxide in the inhibition of cytochrome P450 in the liver of mice infected with Chlamydia trachomatis.
Topics: Animals; Chlamydia Infections; Chlamydia trachomatis; Cytochrome P-450 Enzyme System; Enzyme Induction; Enzyme Inhibitors; Female; Isoenzymes; Liver; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites | 1998 |
Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice.
Topics: Alkaline Phosphatase; Animals; Aorta, Thoracic; Apolipoproteins E; Arteriosclerosis; Chlamydia Infections; Chlamydophila pneumoniae; Cyclooxygenase Inhibitors; Diclofenac; Endothelium, Vascular; Immunohistochemistry; Methacholine Chloride; Mice; Mice, Knockout; Muscarinic Agonists; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norepinephrine; Staining and Labeling; Vasoconstriction | 2000 |